Brown, Lisle/Cummings’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
VCM
VPM
Brown, Lisle/Cummings's MDT Position: Q1 2026 in Review
Brown, Lisle/Cummings increased its Medtronic (MDT) stake by 7.4% in Q1 2026, buying an estimated $8.81K and bringing the position to 1,329 shares worth $115K. The position accounts for 0.03% of the portfolio, ranked #273.
Brown, Lisle/Cummings first reported a position in MDT in Q4 2021 and has held it in 18 quarters since. The position peaked at $146K in Q1 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Brown, Lisle/Cummings held 1,329 shares of Medtronic worth $115K as of Q1 2026.
- Brown, Lisle/Cummings bought 92 Medtronic shares in Q1 2026, an estimated $8.81K.
- Medtronic made up 0.03% of Brown, Lisle/Cummings's portfolio in Q1 2026, its #273 holding.
- Brown, Lisle/Cummings first reported a position in Medtronic in Q4 2021 and has held it in 18 quarters since.
- Brown, Lisle/Cummings's Medtronic position peaked at $146K in Q1 2025.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Brown, Lisle/Cummings's 13F filing for Q1 2026, filed 20 Apr 2026.